TY  - GEN
AU  - Sheng,Guangying
AU  - Chen,Suning
AU  - Dong,Chaohui
AU  - Zhang,Ri
AU  - Miao,Miao
AU  - Wu,Depei
AU  - Tan,Seng Chuen
AU  - Liu,Chao
AU  - Xiong,Tengbin
TI  - Societal implications of medical insurance coverage for imatinib as first-line treatment of chronic myeloid leukemia in China: a cost-effectiveness analysis
SN  - 1941-837X
PY  - 2017///1011
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - China
KW  - Cost-Benefit Analysis
KW  - Decision Support Techniques
KW  - Humans
KW  - Imatinib Mesylate
KW  - Insurance Coverage
KW  - economics
KW  - Insurance, Health
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - drug therapy
KW  - Markov Chains
KW  - Pyrimidines
KW  - Quality-Adjusted Life Years
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1080/13696998.2016.1271336
ER  -